Entact Bio: Funding, Investors & Team (Oct 2026)
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
Entact Bio has raised $91.0M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Entact Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Entact Bio Funding Rounds
Entact Bio raised $81.0M in a Series A announced in Dec 2022.
3.5 years later, an undisclosed round of $10.0M was announced in Jun 2026.
Entact Bio Founders and Leadership Team
Contact details for the Entact Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Entact Bio Funding Compared to Other Biotechnology Startups
Entact Bio's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entact Bio in Biotechnology and Watertown
Companies Similar to Entact Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Entact Bio Funding FAQs
What does Entact Bio do?
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
How much funding has Entact Bio raised?
Entact Bio has raised $91.0M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Jun 2026.
When did Entact Bio last raise funding?
Entact Bio's most recent funding round on record is an undisclosed round of $10.0M, announced in Jun 2026.
Who is the CEO of Entact Bio?
Victoria Richon is listed as CEO at Entact Bio.
Where is Entact Bio headquartered?
Entact Bio is based in Watertown, Massachusetts, United States.
How many employees does Entact Bio have?
Entact Bio is in the 11-50 employee band.
How does Entact Bio's funding compare to other Biotechnology startups?
Entact Bio's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Entact Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entact Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.